Default company panoramic image
Logo

DermaFlow

Detecting non-invasively earliest signs of acute & chronic health status; products transitioning hospital, out-patient & home/remote.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location United States
  • Currency USD
  • Founded November 2011
  • Employees 4
  • Website derma-flow.com

Company Summary

Microcirculation is a well known & researched parameter, but a device having optimal attributes for routine assessment has not emerged to date. First signs of change in acute and chronic health status occur in peripheral blood flow. Mission to provide non-invasive products allowing cost-effective & routine assessment of capillary blood flow changes, i.e. microcirculation. Targeting vital care,hemodynamics, wound healing and chronic disease.

Team

  • Default avatar
    Dr. Irene Jaffe
    Chief Executive Officer

  • Default avatar
    Ilya Skoletsky
    Chief Technology Officer

  • Default avatar
    Dr. Daniel Weiss
    Chief Medical Officer

  • Default avatar
    James Kleinburd
    Chairman of the Board

  • Default avatar
    Bruce Anderson
    SVP and Manager of US Operations

Advisors

  • Default avatar
    David Gitlin, Esq., GreenbergTraurig, Philadephia, PA
    Lawyer
    Unconfirmed
    Default avatar
    David Evans, Cherry Hill, NJ
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Dotan Technologies Ltd.
    Unconfirmed